Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Pebble Gro. Regulatory News (PEBB)

Share Price Information for The Pebble Gro. (PEBB)

Share Price is delayed by 15 minutes
Get Live Data
56.50    -0.50 (-0.88%)
Bid:
55.00
Ask:
58.00
Spread: 3.00 (5.455%)
Market Cap: £78.77m
PEBB Live PriceLast checked at - London Stock Exchange

Intraday The Pebble Gro. Share Chart

Non-Executive Chair Appointment

9 Sep 2024 07:00

RNS Number : 3287D
Pebble Group PLC (The)
09 September 2024
 

9 September 2024

THE PEBBLE GROUP PLC

("The Pebble Group" or the "Group")

AIM: PEBB, OTCQX: PEBBF

Non-Executive Chair Appointment

The Pebble Group, a leading provider of digital commerce, products and related services to the global promotional products industry, is pleased to announce the appointment of Anne de Kerckhove to the Board of Directors of The Pebble Group as independent Non-Executive Chair with immediate effect.

The appointment marks the conclusion of a comprehensive search and appointment process for a permanent Non-Executive Chair following the Company's announcement on 30 April 2024. Chris Lee will cease to act as Interim Executive Chair with immediate effect and will continue as Chief Executive Officer of the Group.

Anne is a highly accomplished international executive with over 20 years' experience in technology and innovation in the UK and across Europe, leading and scaling fast-growing companies in SaaS, data, media and entertainment and digital commerce. Anne has extensive Executive and Non-Executive experience and is actively involved in promoting women on boards and within the technology industry.

Chris Lee, Chief Executive Officer, said: "I am delighted to welcome Anne to The Pebble Group. Anne's significant experience will further strengthen the Board's expertise and be particularly valuable as we push to deliver Facilisgroup's technology and product innovation strategy."

Anne de Kerckhove, Non-Executive Chair, said: "I am excited to be joining the Board of The Pebble Group. The Group has an impressive track record, blue-chip clients and two strong businesses with differentiated market positions. I look forward to working closely with the Board and the leadership teams to scale the businesses and deliver long-term sustainable growth for all of its stakeholders."

Anne will be Chair of the Nomination Committee and will sit on the Audit and Remuneration Committees.

Enquiries

The Pebble Group

Chris Lee, Chief Executive Officer

Claire Thomson, Chief Financial Officer

+44 (0) 750 012 4121

Panmure Liberum (Nominated Adviser and Broker)

Edward Mansfield

Will King

Josh Moss

+44 (0) 20 3100 2000

Temple Bar Advisory (Financial PR)

Alex Child-Villiers

Alistair de Kare-Silver

Sam Livingstone

+44 (0) 207 183 1190

pebble@templebaradvisory.com

 

In accordance with Schedule 2 (g) of the AIM Rules for Companies, Anne Isabelle de Kerckhove (aged 51 years) holds/has held the following directorships/partnerships in the last five years:

 

Current directorships/partnerships

Previous directorships/partnerships (last five years)

Blackbird plc

Eagle Eye Solutions Group plc

7digital SAS

Evoke plc

DNA Bridge Limited

Hub Investments Holding Limited

Kaisa Technologies AB

Moneyhub Financial Technology Limited

Kaisa Technologies Ltd

UK-Evoke

 

Save for the information set out above, there are no further disclosures to be made in accordance with Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in respect of the appointment of Anne de Kerckhove. Anne de Kerckhove does not hold any beneficial interest in the Company's share capital.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAPNPEDELEFA
Date   Source Headline
17th Jun 20267:00 amRNSTransaction in Own Shares
16th Jun 20267:00 amRNSTransaction in Own Shares
11th Jun 20267:00 amRNSTransaction in Own Shares
10th Jun 20263:49 pmRNSHolding(s) in Company
10th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20263:41 pmRNSHolding(s) in Company
5th Jun 20263:39 pmRNSHolding(s) in Company
4th Jun 20264:32 pmRNSHolding(s) in Company
3rd Jun 20267:00 amRNSTransaction in Own Shares
26th May 20265:50 pmRNSBlock Admission Return
14th May 20265:06 pmRNSDirector/PDMR Shareholding
13th May 20264:55 pmRNSHolding(s) in Company
8th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20262:31 pmRNSResult of Annual General Meeting 2026
29th Apr 20267:00 amRNSAGM Trading Update and Notice of Results
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 202612:21 pmRNSPurchase of Shares by Employee Benefit Trust
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 202610:30 amRNSHolding(s) in Company
14th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20264:02 pmRNSHolding(s) in Company
30th Mar 20262:08 pmRNSHolding(s) in Company
30th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNS2025 Annual Report, ESG Report and Notice of AGM
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSLaunch of Share Buyback Programme
17th Mar 20267:00 amRNSLaunch of Share Buyback Programme
17th Mar 20267:00 amRNSAUDITED FULL YEAR RESULTS 2025
17th Mar 20267:00 amRNSAUDITED FULL YEAR RESULTS 2025
13th Feb 202612:22 pmRNSHolding(s) in Company
2nd Feb 20265:23 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSTrading Update and Notice of Results
13th Jan 20266:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.